메뉴 건너뛰기




Volumn 21, Issue 6, 2008, Pages 497-503

The relationship of hepatitis antibodies and elevated liver enzymes with impaired fasting glucose and undiagnosed diabetes

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY; LIVER ENZYME;

EID: 56749179189     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2008.06.080047     Document Type: Article
Times cited : (19)

References (23)
  • 1
    • 34249674023 scopus 로고    scopus 로고
    • Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: Role of increase rates of gluconeogenesis
    • Bock G, Chittilapilly E, Basu R, et al. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increase rates of gluconeogenesis. Diabetes 2007:7:1703-11.
    • (2007) Diabetes , vol.7 , pp. 1703-1711
    • Bock, G.1    Chittilapilly, E.2    Basu, R.3
  • 2
    • 33646782893 scopus 로고    scopus 로고
    • Distinguishing nonalcoholic statohepatitis from fatty liver: Serum-free fatty acids, insulin resistance, and serum lipoproteins
    • Bookman ID, Pham J, Guindi M, Heathcote EJ. Distinguishing nonalcoholic statohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins. Liver Int 2006;26:566-71.
    • (2006) Liver Int , vol.26 , pp. 566-571
    • Bookman, I.D.1    Pham, J.2    Guindi, M.3    Heathcote, E.J.4
  • 3
    • 33847316067 scopus 로고    scopus 로고
    • Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2
    • Kawaguchi T, Ide T, Taniguchi E, et al. Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2. Am J Gastroenterol 2007;102:570-6.
    • (2007) Am J Gastroenterol , vol.102 , pp. 570-576
    • Kawaguchi, T.1    Ide, T.2    Taniguchi, E.3
  • 4
    • 21544436004 scopus 로고    scopus 로고
    • Liver enzymes, the metabolic syndrome, and incident diabetes: The Mexico City diabetes study
    • Nannipieri M, Gonzales C, Baldi S, et al. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care 2005;28:1757-62.
    • (2005) Diabetes Care , vol.28 , pp. 1757-1762
    • Nannipieri, M.1    Gonzales, C.2    Baldi, S.3
  • 5
    • 4644337374 scopus 로고    scopus 로고
    • Elevations in markers of liver injury and risk of type 2 diabetes: The insulin resistance atherosclerosis study
    • Hanley AJ, Williams K, Festa A, et al. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2004;53:2623-32.
    • (2004) Diabetes , vol.53 , pp. 2623-2632
    • Hanley, A.J.1    Williams, K.2    Festa, A.3
  • 6
    • 34547931223 scopus 로고    scopus 로고
    • Liver enzymes as a predictor for incident diabetes in a Japanese population: The Hisayama study
    • Doi Y, Kubo M, Yonemoto K, et al. Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study. Obesity 2007;15:1841-50.
    • (2007) Obesity , vol.15 , pp. 1841-1850
    • Doi, Y.1    Kubo, M.2    Yonemoto, K.3
  • 7
    • 38749102436 scopus 로고    scopus 로고
    • Liver enzymes and risk of diabetes and cardiovascular disease: Results of the Firenze Bagno a Ripoli (FIBAR) study
    • Monami M, Bardini G, Lamanna C, et al. Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. Metabolism 2008;57:387-92.
    • (2008) Metabolism , vol.57 , pp. 387-392
    • Monami, M.1    Bardini, G.2    Lamanna, C.3
  • 8
    • 33644823983 scopus 로고    scopus 로고
    • Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men
    • Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 2005;28:2913-8.
    • (2005) Diabetes Care , vol.28 , pp. 2913-2918
    • Wannamethee, S.G.1    Shaper, A.G.2    Lennon, L.3    Whincup, P.H.4
  • 9
    • 33845544078 scopus 로고    scopus 로고
    • Relationship of metabolic risk factors and development of cardiovascular disease and diabetes
    • Haffner SM. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity 2006;14 Suppl 3:121S-7S.
    • (2006) Obesity , vol.14 , Issue.SUPPL. 3
    • Haffner, S.M.1
  • 10
    • 9244242904 scopus 로고    scopus 로고
    • Federation meeting: Screening for type 2 diabetes
    • World Health Organization, Geneva: World Health Organization;
    • World Health Organization. Report of a World Health Organization and International Diabetes Federation meeting: screening for type 2 diabetes. Geneva: World Health Organization; 2003.
    • (2003) Report of a World Health Organization and International Diabetes
  • 11
    • 0041886596 scopus 로고    scopus 로고
    • Prevalence of diabetes and impaired fasting glucose in adults - United States, 1999-2000
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention. Prevalence of diabetes and impaired fasting glucose in adults - United States, 1999-2000. MMWR Morb Mortal Wkly Rep 2003;52:833-7.
    • (2003) MMWR Morb Mortal Wkly Rep , vol.52 , pp. 833-837
  • 12
    • 33749608155 scopus 로고    scopus 로고
    • Evidence of nephropathy and peripheral neuropathy in US adults with undiagnosed diabetes
    • Koopman RJ, Mainous AG III, Liszka HA, et al. Evidence of nephropathy and peripheral neuropathy in US adults with undiagnosed diabetes. Ann Fam Med 2006;4:427-32.
    • (2006) Ann Fam Med , vol.4 , pp. 427-432
    • Koopman, R.J.1    Mainous III, A.G.2    Liszka, H.A.3
  • 14
    • 18144425460 scopus 로고    scopus 로고
    • Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance
    • Franciosi M, De Berardis G, Rossi MCE, et al. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance. Diabetes Care 2005;28:1187-94.
    • (2005) Diabetes Care , vol.28 , pp. 1187-1194
    • Franciosi, M.1    De Berardis, G.2    Rossi, M.C.E.3
  • 15
    • 33645473408 scopus 로고    scopus 로고
    • Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index
    • Thomas C, Hyppönen E, Power C. Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index. Arch Intern Med 2006;166:682-8.
    • (2006) Arch Intern Med , vol.166 , pp. 682-688
    • Thomas, C.1    Hyppönen, E.2    Power, C.3
  • 16
    • 33845996154 scopus 로고    scopus 로고
    • Standards of medical care in diabetes, 2007
    • American Diabetes Association
    • American Diabetes Association. Standards of medical care in diabetes, 2007. Diabetes Care 2007;30:S4-S41.
    • (2007) Diabetes Care , vol.30
  • 17
    • 1042268060 scopus 로고    scopus 로고
    • Screening for type 2 diabetes
    • American Diabetes Association
    • American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2004;27:S11-S14.
    • (2004) Diabetes Care , vol.27
  • 18
    • 56749169413 scopus 로고    scopus 로고
    • US Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Rockville (MD): Agency for Healthcare Research and Quality; 2008 June. Publication No. 08-05116-EF-2. Available from http://www.ahrq.gov/clinic/ uspstf08/type2/type2rs.htm. Accessed 2 September 2008.
    • US Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Rockville (MD): Agency for Healthcare Research and Quality; 2008 June. Publication No. 08-05116-EF-2. Available from http://www.ahrq.gov/clinic/ uspstf08/type2/type2rs.htm. Accessed 2 September 2008.
  • 20
    • 56749169411 scopus 로고    scopus 로고
    • National Health and Nutrition Examination Survey. Data Sets and Related Documentation. Available from, Accessed December 2007
    • National Center for Health Statistics, Centers for Disease Control. National Health and Nutrition Examination Survey. Data Sets and Related Documentation. Available from http://www.cdc.gov/nchs/about/major/nhanes/ datalink.htm. Accessed December 2007.
  • 21
    • 56749179517 scopus 로고    scopus 로고
    • Available from, Accessed 12 December 2007
    • National Institute for Alcohol Abuse and Alcoholism. Clinicians Guide 2005. Available from http://pubs.niaaa.nih.gov/publications/Practitioner/ CliniciansGuide2005/clinicians_guide.htm. Accessed 12 December 2007.
    • (2005) Clinicians Guide
  • 22
    • 0037469232 scopus 로고    scopus 로고
    • AHA/CDC Scientific Statement. Markers of inflammation and cardiovascular disease
    • Pearson TA, Mensah GA, Alexander RW, et al. AHA/CDC Scientific Statement. Markers of inflammation and cardiovascular disease. Circulation 2003;107:499-511.
    • (2003) Circulation , vol.107 , pp. 499-511
    • Pearson, T.A.1    Mensah, G.A.2    Alexander, R.W.3
  • 23
    • 0002109787 scopus 로고
    • Cognitive aspects of reporting cancer prevention examination and tests
    • Vital Health Stat, Washington DC: National Center for Health Statistics;
    • Sudman S, Warnecke R, Johnson T, O'Rourke D, Davis AM. Cognitive aspects of reporting cancer prevention examination and tests. Vital Health Stat, series 6, number 7. Washington DC: National Center for Health Statistics; 1994.
    • (1994) series , vol.6 , Issue.7
    • Sudman, S.1    Warnecke, R.2    Johnson, T.3    O'Rourke, D.4    Davis, A.M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.